Search results
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
Zacks· 2 days agoThe FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
This Stock Has Gained 150% Since I Bought It – but It Could Still Be a Bargain | The Motley Fool
The Motley Fool· 5 days agoI bought this bank stock during the initial COVID-19 crash, and I'm sure glad I did.
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 5 days agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company sells. There are dozens of innovative medicines in ...
Dividend Deals: 3 Overlooked Stocks Offering Incredible Value
InvestorPlace· 4 days agoThere is no joy like receiving passive income each quarter. If you seek steady dividend income and long-term growth, consider the overlooked dividend stocks mentioned here. Whether you are only ...